#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Arteriosclerosis

Not recruiting

Investigational

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Pelacarsen

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Tanimilast

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Salbutamol

Contact Research Centre

Major depression

Not recruiting

Investigational

Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Lavender Oil

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drug

Study of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Obesity+1

Not recruiting

Investigational

Study on the Effectiveness of Orforglipron for Patients with Obstructive Sleep Apnea and Obesity or Overweight

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-Pyran-4-Yl)-2-((S)-3-(3-(4-Fluoro-1-Methyl-1H-Indazol-5-Yl)-2-Oxo-2,3-Dihydro-1H-Imidazol-1-Yl)-2-(4-Fluoro-3,5-Dimethylphenyl)-4-Methyl-4,5,6,7-Tetrahydro-2H-Pyrazolo[4,3-C]Pyridine-5-Carbonyl)-1H-Indol-1-Yl)-2-Methylcyclopropyl)-5-Oxo-1,2,4-Oxadiazol-4-Ide Hemicalcium

Contact Research Centre

Impaired gastric emptying+1

Not recruiting

Investigational

Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Naronapride Dihydrochloride Trihydrate

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.